Tuesday, July 16, 2019
Home 2019

Yearly Archives: 2019

Israel

A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.

Editor / Curator -
Research

Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.

Editor / Curator -
eCommerce

MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)

Editor / Curator -
nanovibronix, biotech stock review
Biotech News

Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.

Editor / Curator -
Israel tech stocks
Israel

Israeli Tech Stocks Raise $165 Million on Toronto TSX, Bypassing NASDAQ.

Editor / Curator -
Internet Stock Review
Featured

Baltimore’s $10 Million Problem is Just the Tip of the Iceberg.

Editor / Curator -
Research

Mustang Bio (MBIO) $3.40 Gets $7 Price Target from Cantor. (SeekingAlpha.)

Editor / Curator -
redefy
IPOS

Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.

Editor / Curator -
orchestra biomed
Biotech News

Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.

Editor / Curator -
ecuador gold
Precious Metals

Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky...

Editor / Curator -
123...10Page 1 of 10

Latest article

A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.

Israel Editor / Curator -
With Toronto Grabbing Some of the Best Israeli Tech Listings Away From NASDAQ, We Saw This Coming. From...

Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.

Research Editor / Curator -
Internet Stock Review Adds Duos Technologies ($0.70) to Watch List. Graduates to OTCQX 6/20/19. Duos Technologies Website. Presentation...

MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)

eCommerce Editor / Curator -
AIRPORT CITY, Israel, June 27, 2019 /PRNewswire/ -- My Size, Inc. (the "Company" or "My Size") (MYSZ) (MYSZ), the developer and creator of smartphone measurement solutions,...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.